Shift in the Dominant Sequence Type of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection from ST11 to ST15 at a Medical Center in Northeast China, 2015–2020

References

• Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344–359. doi:10.1038/s41579-019-0315-132055025
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-131478103
   PubMed Web of Science ®Google Scholar
• Li Y, Li J, Hu T, et al. Five-year change of prevalence and risk factors for infection and mortality of Carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China. Antimicrob Resist Infect Control. 2020;9(1):79. doi:10.1186/s13756-020-00728-332487221
   PubMed Web of Science ®Google Scholar
• Xiao T, Zhu Y, Zhang S, et al. A retrospective analysis of risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174–S183. doi:10.1093/infdis/jiz55932176799
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with Carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-328356109
   PubMed Web of Science ®Google Scholar
• Karakonstantis S, Kritsotakis EI, Gikas A. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection. 2020;48(6):835–851. doi:10.1007/s15010-020-01520-632875545
   PubMed Web of Science ®Google Scholar
• Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 Carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.00432971292
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
   PubMed Web of Science ®Google Scholar
• Su S, Zhang J, Zhao Y, et al. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics. BMC Infect Dis. 2020;20(1):472. doi:10.1186/s12879-020-05143-y32616018
   PubMed Web of Science ®Google Scholar
• Zhan L, Wang S, Guo Y, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol. 2017;7:182. doi:10.3389/fcimb.2017.0018228560183
   PubMed Web of Science ®Google Scholar
• Li D, Liao W, Huang HH, et al. Emergence of hypervirulent ceftazidime/avibactam-resistant Klebsiella pneumoniae isolates in a Chinese Tertiary Hospital. Infect Drug Resist. 2020;13:2673–2680. doi:10.2147/IDR.S25747732821131
   PubMed Web of Science ®Google Scholar
• Rao K, Seekatz A, Bassis C, et al. Enterobacterales infection after intestinal dominance in hospitalized patients. mSphere. 2020;5(4). doi:10.1128/mSphere.00450-20
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M. How to manage KPC infections. Ther Adv Infect Dis. 2020;7:2049936120912049. doi:10.1177/204993612091204932489663
   PubMed Web of Science ®Google Scholar
• Pryor R, Viola-Luqa C, Hess O, et al. Barrier precautions in the era of multidrug pathogens. Curr Treat Options Infect Dis. 2020:1–11. doi:10.1007/s40506-020-00230-9
   Google Scholar
• Bush K, Bradford PA. Epidemiology of beta-lactamase-producing pathogens. Clin Microbiol Rev. 2020;33(2).
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of Carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20(1):822. doi:10.1186/s12864-019-6225-931699025
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang K, Chen W, et al. Epidemiological characteristics of Carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China. Antimicrob Resist Infect Control. 2020;9(1):15. doi:10.1186/s13756-019-0674-431956404
   PubMed Web of Science ®Google Scholar
• Han Y, Huang L, Liu C, et al. Characterization of Carbapenem-resistant Klebsiella pneumoniae ST15 clone coproducing KPC-2, CTX-M-15 and SHV-28 spread in an intensive care unit of a Tertiary Hospital. Infect Drug Resist. 2021;14:767–773. doi:10.2147/IDR.S29851533688212
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu PP, Wang LH, et al. Capsular polysaccharide types and virulence-related traits of epidemic KPC-producing Klebsiella pneumoniae isolates in a Chinese University Hospital. Microb Drug Resist. 2017;23(7):901–907. doi:10.1089/mdr.2016.022228437231
   PubMed Web of Science ®Google Scholar
• Liu C, Du P, Zhao J, et al. Phenotypic and genomic characterization of virulence heterogeneity in multidrug-resistant ST11 Klebsiella pneumoniae during inter-host transmission and evolution. Infect Drug Resist. 2020;13:1713–1721. doi:10.2147/IDR.S24383632606821
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang S, Fang R, et al. Dynamic epidemiology and virulence characteristics of Carbapenem-resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016. Infect Drug Resist. 2020;13:931–940. doi:10.2147/IDR.S24303232280249
   PubMed Web of Science ®Google Scholar
• Hussein K, Raz-Pasteur A, Finkelstein R, et al. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83(4):307–313. doi:10.1016/j.jhin.2012.10.01223313086
   PubMed Web of Science ®Google Scholar
• Ho VP, Kaafarani H, Rattan R, et al. Sepsis 2019: what surgeons need to know. Surg Infect (Larchmt). 2020;21(3):195–204. doi:10.1089/sur.2019.12631755816
   PubMed Web of Science ®Google Scholar